CYTK
Cytokinetics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.54B
P/E Ratio
—
EPS
$-6.54
Beta
0.48
52W High
$70.98
52W Low
$29.31
50-Day MA
$64.04
200-Day MA
$57.28
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
117.65
PEG Ratio
-0.42
About Cytokinetics Inc
Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $88.04M |
| Gross Profit (TTM) | $-327.99M |
| EBITDA | $-602.13M |
| Operating Margin | -1005.00% |
| Return on Equity | -572.00% |
| Return on Assets | -27.10% |
| Revenue/Share (TTM) | $0.73 |
| Book Value | $-5.37 |
| Price-to-Book | 60.31 |
| Price-to-Sales (TTM) | 85.64 |
| EV/Revenue | 91.49 |
| EV/EBITDA | -15.82 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 4.90% |
| Shares Outstanding | $124.24M |
| Float | $122.52M |
| % Insiders | 0.84% |
| % Institutions | 114.25% |
Historical Volatility
HV 10-Day
32.67%
HV 20-Day
29.14%
HV 30-Day
32.24%
HV 60-Day
41.12%
HV Rank
0.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($92.94 target)
7
Strong Buy10
Buy3
HoldData last updated: 4/29/2026